Jiuling Yang

961 total citations
10 papers, 531 citations indexed

About

Jiuling Yang is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Jiuling Yang has authored 10 papers receiving a total of 531 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 3 papers in Oncology and 3 papers in Immunology. Recurrent topics in Jiuling Yang's work include Ubiquitin and proteasome pathways (5 papers), Protein Degradation and Inhibitors (4 papers) and Extracellular vesicles in disease (2 papers). Jiuling Yang is often cited by papers focused on Ubiquitin and proteasome pathways (5 papers), Protein Degradation and Inhibitors (4 papers) and Extracellular vesicles in disease (2 papers). Jiuling Yang collaborates with scholars based in United States, China and Poland. Jiuling Yang's co-authors include Yangbing Li, Shaomeng Wang, Angelo Aguilar, Chao‐Yie Yang, Liu Liu, Donna McEachern, Xin Han, Mi Wang, Sally Przybranowski and Zhaomin Liu and has published in prestigious journals such as Cell, PLoS ONE and Cancer Research.

In The Last Decade

Jiuling Yang

10 papers receiving 525 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jiuling Yang United States 8 445 220 104 64 32 10 531
Zhengnian Li United States 10 475 1.1× 207 0.9× 109 1.0× 54 0.8× 30 0.9× 16 592
Marja Dubay United States 11 477 1.1× 168 0.8× 124 1.2× 43 0.7× 36 1.1× 14 567
Sondra L. Downey-Kopyscinski United States 10 445 1.0× 233 1.1× 111 1.1× 34 0.5× 33 1.0× 19 506
Shenxin Zeng China 13 429 1.0× 215 1.0× 138 1.3× 88 1.4× 25 0.8× 33 556
Stacey-Lynn Paiva United States 7 499 1.1× 213 1.0× 88 0.8× 27 0.4× 25 0.8× 16 549
Yu-Gang Song China 4 440 1.0× 200 0.9× 101 1.0× 28 0.4× 26 0.8× 10 519
Anna Koren Austria 10 473 1.1× 178 0.8× 34 0.3× 39 0.6× 30 0.9× 17 583
Sarah Vittori United States 5 725 1.6× 164 0.7× 92 0.9× 25 0.4× 48 1.5× 5 782
Matthias Brand Germany 11 832 1.9× 379 1.7× 150 1.4× 48 0.8× 49 1.5× 29 977
Maria Goralski United States 4 599 1.3× 175 0.8× 92 0.9× 51 0.8× 17 0.5× 4 684

Countries citing papers authored by Jiuling Yang

Since Specialization
Citations

This map shows the geographic impact of Jiuling Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jiuling Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jiuling Yang more than expected).

Fields of papers citing papers by Jiuling Yang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jiuling Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jiuling Yang. The network helps show where Jiuling Yang may publish in the future.

Co-authorship network of co-authors of Jiuling Yang

This figure shows the co-authorship network connecting the top 25 collaborators of Jiuling Yang. A scholar is included among the top collaborators of Jiuling Yang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jiuling Yang. Jiuling Yang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Yang, Jiuling, James R. Byrnes, Lisa L. Kirkemo, et al.. (2024). PVRL2 Suppresses Antitumor Immunity through PVRIG- and TIGIT-independent Pathways. Cancer Immunology Research. 12(5). 575–591. 7 indexed citations
2.
Chen, Kevin Y., Marco De Giovanni, Ying Xu, et al.. (2024). Inflammation switches the chemoattractant requirements for naive lymphocyte entry into lymph nodes. Cell. 188(4). 1019–1035.e22. 14 indexed citations
3.
Aguilar, Angelo, Jiuling Yang, Yangbing Li, et al.. (2024). Discovery of MD-265: A Potent MDM2 Degrader That Achieves Complete Tumor Regression and Improves Long-Term Survival of Mice with Leukemia. Journal of Medicinal Chemistry. 67(21). 19503–19518. 5 indexed citations
4.
Kirkemo, Lisa L., Susanna K. Elledge, Jiuling Yang, et al.. (2022). Cell-surface tethered promiscuous biotinylators enable comparative small-scale surface proteomic analysis of human extracellular vesicles and cells. eLife. 11. 24 indexed citations
5.
He, Sijia, Yajing Fu, Jia Guo, et al.. (2019). Cofilin hyperactivation in HIV infection and targeting the cofilin pathway using an anti-α 4 β 7 integrin antibody. Science Advances. 5(1). eaat7911–eaat7911. 14 indexed citations
6.
Yang, Jiuling, Yangbing Li, Angelo Aguilar, et al.. (2019). Simple Structural Modifications Converting a Bona fide MDM2 PROTAC Degrader into a Molecular Glue Molecule: A Cautionary Tale in the Design of PROTAC Degraders. Journal of Medicinal Chemistry. 62(21). 9471–9487. 138 indexed citations
7.
Li, Yangbing, Jiuling Yang, Angelo Aguilar, et al.. (2018). Discovery of MD-224 as a First-in-Class, Highly Potent, and Efficacious Proteolysis Targeting Chimera Murine Double Minute 2 Degrader Capable of Achieving Complete and Durable Tumor Regression. Journal of Medicinal Chemistry. 62(2). 448–466. 241 indexed citations
8.
Yang, Jiuling, Yangbing Li, Angelo Aguilar, et al.. (2018). Abstract 4870: Targeted MDM2 degradation as a novel and efficacious cancer therapy. Cancer Research. 78(13_Supplement). 4870–4870. 1 indexed citations
9.
Karataş, Hacer, Yangbing Li, Liu Liu, et al.. (2017). Discovery of a Highly Potent, Cell-Permeable Macrocyclic Peptidomimetic (MM-589) Targeting the WD Repeat Domain 5 Protein (WDR5)–Mixed Lineage Leukemia (MLL) Protein–Protein Interaction. Journal of Medicinal Chemistry. 60(12). 4818–4839. 75 indexed citations
10.
Yan, Kaowen, Wenrui Xu, Jiuling Yang, et al.. (2012). LAPTM4B Allele *2 Is a Marker of Poor Prognosis for Gallbladder Carcinoma. PLoS ONE. 7(9). e45290–e45290. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Zhengnian Li Breakdown of academic impact, for papers by Marja Dubay Breakdown of academic impact, for papers by Sondra L. Downey-Kopyscinski Breakdown of academic impact, for papers by Shenxin Zeng Breakdown of academic impact, for papers by Stacey-Lynn Paiva Breakdown of academic impact, for papers by Yu-Gang Song Breakdown of academic impact, for papers by Anna Koren Breakdown of academic impact, for papers by Sarah Vittori Breakdown of academic impact, for papers by Matthias Brand Breakdown of academic impact, for papers by Maria Goralski
Rankless by CCL
2026